Thyroid nodules: how to assess the risk of malignancy?

被引:0
|
作者
Cao, C. Do [1 ]
Ladsous, M. [1 ,2 ]
机构
[1] CHRU Lille, Hop Claude Huriez, Serv Endocrinol, Lille, France
[2] Ctr Hosp Valenciennes, Serv Endocrinol, Valenciennes, France
关键词
Thyroid nodule; Thyroid ultrasound; Thyroid cytology; Indeterminate cytology; Molecular markers; ASSOCIATION GUIDELINES; MANAGEMENT; SYSTEM;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
About 90 to 95% of thyroid nodules are benign and will required a basic follow-up. Ultrasound evaluation and cytological analysis for selected nodules, with formal reports made according to respective EU-TIRADS (European -Thyroid Imaging Reporting and Data System) classification and Bethesda system, can provide a quantification of malignancy risk and allow to adjust clinical and sonographic monitoring and to elaborate surgical treatment. In case of non-diagnostic (Bethesda 1) or indeterminate (Bethesda III and IV) cytologie one has to discuss reassessment and follow-up, and second line tools like elastography, scintiscan imaging and cytological molecular markers, if cost-effective.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 50 条
  • [41] Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review
    Rao, Karthik Nagaraja
    Randolph, Gregory W.
    Lopez, Fernando
    Zafereo, Mark
    Coca-Pelaz, Andres
    Piazza, Cesare
    Dange, Prajwal
    Rodrigo, Juan Pablo
    Stenman, Goeran
    de Keizer, Bart
    Nixon, Iain
    Sinha, Shriyash
    Leboulleux, Sophie
    Maekitie, Antti A.
    Agaimy, Abbas
    Thompson, Lester
    Ferlito, Alfio
    ENDOCRINE, 2024, 85 (02) : 473 - 492
  • [42] Risk for malignancy of thyroid nodules as assessed by sonographic criteria - The need for biopsy
    Iannuccilli, JD
    Cronan, JJ
    Monchik, JM
    JOURNAL OF ULTRASOUND IN MEDICINE, 2004, 23 (11) : 1455 - 1464
  • [43] Do thyroid nodules that arise in the isthmus have a higher risk of malignancy?
    Pastorello, Ricardo
    Valerio, Ediel
    Lobo, Alberto
    Maia, Antonio
    Saieg, Mauro
    CANCER CYTOPATHOLOGY, 2020, 128 (08) : 520 - 522
  • [44] The impact of race and ethnicity on thyroid nodules, malignancy risk, and surgical management
    Ramonell, Kimberly M.
    Yip, Linwah
    AMERICAN JOURNAL OF SURGERY, 2022, 223 (04): : 615 - 616
  • [45] Can Clinical Presentation and Ultrasonography Predict the Risk of Malignancy in Thyroid Nodules?
    Davoudi, Zahra
    Chouhdari, Arezoo
    Bahrami-Motlagh, Hooman
    Bagheri, Karim
    MIDDLE EAST JOURNAL OF CANCER, 2019, 10 (03) : 246 - 253
  • [46] Impact of Microcalcifications on Risk of Malignancy in Thyroid Nodules with Indeterminate or Benign Cytology
    Brophy, Catherine
    Stewart, James
    O'Donovan, Neil
    McCarthy, Julie
    Murphy, Matthew
    Sheahan, Patrick
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 154 (01) : 46 - 51
  • [47] TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients
    Alaraifi, Abdulaziz K.
    Alessa, Mohammed
    Hijazi, Leen O.
    Alayed, Areej M.
    Alsalem, Abdulaziz A.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2023, 43 (03) : 183 - 188
  • [48] Thyroid Nodules in Severely Obese Patients: Frequency and Risk of Malignancy on Ultrasonography
    de Siqueira, Raquel Andrade
    dos Santos Rodrigues, Ana Paula
    Miamae, Lucas Massao
    Tomimori, Eduardo Kiyoshi
    Silveira, Erika Aparecida
    ENDOCRINE RESEARCH, 2020, 45 (01) : 9 - 16
  • [49] RISK OF MALIGNANCY IN COLD THYROID NODULES . A REPORT OF 607 OPERATED CASES
    MELLIERE, D
    MASSIN, JP
    CALMETTES, C
    CHIGOT, JP
    SAVOIE, JC
    GARNIER, H
    PRESSE MEDICALE, 1970, 78 (07): : 311 - +
  • [50] Risk factors for malignancy in patients with solitary thyroid nodules and their impact on the management
    Tai, Jun D.
    Yang, Jin L.
    Wu, Si C.
    Wang, Bin W.
    Chang, Cong J.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (03) : 379 - 383